Literature DB >> 18975116

Preparation and solid-state characterization of inclusion complexes formed between miconazole and methyl-beta-cyclodextrin.

Andreza Ribeiro1, Ana Figueiras, Delfim Santos, Francisco Veiga.   

Abstract

The aim of this study is to confirm the formation of inclusion complexes between miconazole (MCZ) and two derivatives of beta-cyclodextrin, methyl-beta-cyclodextrin (MbetaCD) and 2-hydroxypropyl-beta-cyclodextrin (HPbetaCD) in aqueous solution by phase solubility studies. Inclusion complexes with MbetaCD in the solid state were then prepared by different methods, i.e., kneading, coevaporation (COE), spray-drying (SD), and lyophilization (LPh). The physicochemical properties of these complexes were subsequently studied by means of differential scanning calorimetry, Fourier transform infrared spectroscopy, scanning electron microscopy, and X-ray diffraction techniques. Phase solubility diagrams with MbetaCD and HPbetaCD were classified as A(P) type, indicating the formation of 1:1 and 1:2 stoichiometric inclusion complexes. The apparent stability constants (K(S)) calculated from the phase solubility diagram were 145.69 M(-1) (K(1:1)) and 11.11 M(-1) (K(1:2)) for MbetaCD and 126.94 M(-1) (K(1:1)) and 2.20 M(-1) (K(1:2)) for HPbetaCD. The method of preparation of the inclusion complexes in the solid state was shown to greatly affect the properties of the formed complex. Hence, the LPh, SD, and COE methods produce true inclusion complexes between MCZ and MbetaCD. In contrast, crystalline drug was still clearly detectable in the kneaded (KN) product.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18975116      PMCID: PMC2628269          DOI: 10.1208/s12249-008-9143-8

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  24 in total

1.  Industrial Applications of Cyclodextrins.

Authors:  Allan R. Hedges
Journal:  Chem Rev       Date:  1998-07-30       Impact factor: 60.622

2.  Cyclodextrins in nasal drug delivery.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-03-01       Impact factor: 15.470

3.  Analysis of miconazole and econazole in pharmaceutical formulations by derivative UV spectroscopy and liquid chromatography (HPLC).

Authors:  V Cavrini; A M Di Pietra; R Gatti
Journal:  J Pharm Biomed Anal       Date:  1989       Impact factor: 3.935

4.  Cyclodextrins as permeation enhancers: some theoretical evaluations and in vitro testing.

Authors:  M Másson; T Loftsson; G Másson; E Stefánsson
Journal:  J Control Release       Date:  1999-05-01       Impact factor: 9.776

Review 5.  Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization.

Authors:  T Loftsson; M E Brewster
Journal:  J Pharm Sci       Date:  1996-10       Impact factor: 3.534

6.  Evaluation of buccal methyl-beta-cyclodextrin toxicity on human oral epithelial cell culture model.

Authors:  Laïla Boulmedarat; Amélie Bochot; Sylviane Lesieur; Elias Fattal
Journal:  J Pharm Sci       Date:  2005-06       Impact factor: 3.534

7.  Investigation and physicochemical characterization of vinpocetine-sulfobutyl ether beta-cyclodextrin binary and ternary complexes.

Authors:  Laura Ribeiro; Thorsteinn Loftsson; Domingos Ferreira; Francisco Veiga
Journal:  Chem Pharm Bull (Tokyo)       Date:  2003-08       Impact factor: 1.645

8.  Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl-beta-cyclodextrin.

Authors:  M Charoenchaitrakool; F Dehghani; N R Foster
Journal:  Int J Pharm       Date:  2002-06-04       Impact factor: 5.875

9.  Interactions of griseofulvin with cyclodextrins in solid binary systems.

Authors:  M D Veiga; P J Díaz; F Ahsan
Journal:  J Pharm Sci       Date:  1998-07       Impact factor: 3.534

10.  Theoretical and experimental vibrational study of miconazole and its dimers with organic acids: application to the IR characterization of its inclusion complexes with cyclodextrins.

Authors:  Valéry Barillaro; Georges Dive; Eric Ziémons; Pascal Bertholet; Brigitte Evrard; Luc Delattre; Geraldine Piel
Journal:  Int J Pharm       Date:  2007-09-04       Impact factor: 5.875

View more
  9 in total

1.  Enhanced antiproliferative activity of the new anticancer candidate LPSF/AC04 in cyclodextrin inclusion complexes encapsulated into liposomes.

Authors:  Elisângela A M Mendonça; Mariane C B Lira; Marcelo M Rabello; Isabella M F Cavalcanti; Suely L Galdino; Ivan R Pitta; Maria do Carmo A Lima; Maira G R Pitta; Marcelo Z Hernandes; Nereide S Santos-Magalhães
Journal:  AAPS PharmSciTech       Date:  2012-10-02       Impact factor: 3.246

2.  In vitro and in vivo evaluation of cnicin from blessed thistle (Centaurea benedicta) and its inclusion complexes with cyclodextrins against Schistosoma mansoni.

Authors:  Lucas S Queiroz; Everton Allan Ferreira; Ana C Mengarda; Ayla das C Almeida; Priscila de F Pinto; Elaine S Coimbra; Josué de Moraes; Ângelo M L Denadai; Ademar A Da Silva Filho
Journal:  Parasitol Res       Date:  2020-11-08       Impact factor: 2.289

3.  Improvement of dissolution behavior of poorly water soluble drugs by biodegradable polymeric submicron carriers containing sparingly methylated β-cyclodextrin.

Authors:  Dilesh J Singhavi; Shagufta Khan; Pramod G Yeole
Journal:  J Mater Sci Mater Med       Date:  2013-02-08       Impact factor: 3.896

4.  Synthesis, Spectroscopy, Light Stability, Single-Crystal Analysis, and In Vitro Cytotoxic Activity on HepG2 Liver Cancer of Two Novel Silver(I) Complexes of Miconazole.

Authors:  Karolina Stryjska; Lidia Radko; Lilianna Chęcińska; Joachim Kusz; Andrzej Posyniak; Justyn Ochocki
Journal:  Int J Mol Sci       Date:  2020-05-21       Impact factor: 5.923

5.  Functional characteristics of Bambara groundnut starch-catechin complex formed using cyclodextrins as initiators.

Authors:  Nontobeko B Gulu; Victoria A Jideani; Ayesha Jacobs
Journal:  Heliyon       Date:  2019-04-28

6.  Design and Evaluation of Orally Dispersible Tablets Containing Amlodipine Inclusion Complexes in Hydroxypropyl-β-cyclodextrin and Methyl-β-cyclodextrin.

Authors:  Marian Novac; Adina Magdalena Musuc; Emma Adriana Ozon; Iulian Sarbu; Mirela Adriana Mitu; Adriana Rusu; Simona Petrescu; Irina Atkinson; Daniela Gheorghe; Dumitru Lupuliasa
Journal:  Materials (Basel)       Date:  2022-07-28       Impact factor: 3.748

7.  Formation and Physico-Chemical Evaluation of Nifedipine-hydroxypropyl-β-cyclodextrin and Nifedipine-methyl-β-cyclodextrin: The Development of Orodispersible Tablets.

Authors:  Emma Adriana Ozon; Marian Novac; Daniela Gheorghe; Adina Magdalena Musuc; Mirela Adriana Mitu; Iulian Sarbu; Valentina Anuta; Adriana Rusu; Simona Petrescu; Irina Atkinson; Dumitru Lupuliasa
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-12

8.  SARS-CoV-2 main protease (3CLpro) interaction with acyclovir antiviral drug/methyl-β-cyclodextrin complex: Physiochemical characterization and molecular docking.

Authors:  Sonaimuthu Mohandoss; Ramaraj Sukanya; Sivarasan Ganesan; Fatemah H Alkallas; Amira Ben Gouider Trabelsi; Fedor V Kusmartsev; Kuppu Sakthi Velu; Thambusamy Stalin; Huang-Mu Lo; Yong Rok Lee
Journal:  J Mol Liq       Date:  2022-09-09       Impact factor: 6.633

9.  Structural Analysis of Crystalline R(+)-α-Lipoic Acid-α-cyclodextrin Complex Based on Microscopic and Spectroscopic Studies.

Authors:  Naoko Ikuta; Takatsugu Endo; Shota Hosomi; Keita Setou; Shiori Tanaka; Noriko Ogawa; Hiromitsu Yamamoto; Tomoyuki Mizukami; Shoji Arai; Masayuki Okuno; Kenji Takahashi; Keiji Terao; Seiichi Matsugo
Journal:  Int J Mol Sci       Date:  2015-10-16       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.